Abstract:Research ethics: This study was approved by the Ethics Committee of Hangzhou Xixi Hospital (2023048). Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission. Competing interests: The authors state no conflict of interest. Research funding: None declared. Data availability: The raw data can be obtained on request from the corresponding author. 1. Younossi, ZM, Bernstein, D, Shiffman, ML, Kwo, P, Kim, WR, Kowdley, KV, et al.. Diagnosis and management of primary biliary cholangitis. Am J Gastroenterol 2019;114:48–63. https://doi.org/10.1038/s41395-018-0390-3. Search in Google Scholar 2. Tanaka, A. Current understanding of primary biliary cholangitis. Clin Mol Hepatol 2021;27:1–21. https://doi.org/10.3350/cmh.2020.0028. Search in Google Scholar 3. Hu, S, Zhao, F, Wang, Q, Chen, WX. The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis. Clin Chem Lab Med 2014;52:1533–42. https://doi.org/10.1515/cclm-2013-0926. Search in Google Scholar 4. Muratori, P, Muratori, L, Ferrari, R, Cassani, F, Bianchi, G, Lenzi, M, et al.. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003;98:431–7. https://doi.org/10.1111/j.1572-0241.2003.07257.x. Search in Google Scholar 5. de Liso, F, Matinato, C, Ronchi, M, Maiavacca, R. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature. Clin Chem Lab Med 2017;56:25–31. https://doi.org/10.1515/cclm-2017-0249. Search in Google Scholar 6. Wang, M, Jin, Y, Xu, A. Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis. Clin Chem Lab Med 2024;62:e53–5. https://doi.org/10.1515/cclm-2023-0742. Search in Google Scholar 7. Lindor, KD, Bowlus, CL, Boyer, J, Levy, C, Mayo, M. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases. Hepatology 2019;69:394–419. https://doi.org/10.1002/hep.30145. Search in Google Scholar This article contains supplementary material (https://doi.org/10.1515/cclm-2023-1490). © 2024 Walter de Gruyter GmbH, Berlin/Boston

Significance of Serum Anti-Gp210 Antibody Detection in Diagnosis of Primary Biliary Cirrhosis

Clinical Analysis of Primary Biliary Cirrhosis: a Report of 31 Cases

Diagnostic Significance of Autoantibodies in Patients with Primary Biliary Cirrhosis

Clinical Research of Anti-Gp210 and Anti-Sp100 Antibody in Primary Biliary Cirrhosis Patients

Clinical performance of AMA‐M2, anti‐gp210 and anti‐sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead‐based flow fluorescent immunoassay

Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms

Study of specific autoantibodies in patients with primary biliary cirrhosis

S72 Diagnostic Value of Anti-Mitochondrial Antibodies (AMA), Anti-M2, Anti-sp100, and Anti-gp210 in Primary Biliary Cholangitis (PBC)

Diagnostic value of anti-hexokinase 1 and anti-kelch-like 12 antibodies in primary biliary cholangitis patients

Autoantibodes to Gp210 Are a Metric for Udca Responses in Primary Biliary Cholangitis

Diagnostic value of quantitative chemiluminescence immunoassay for anti-gp210 and anti-sp100 antibodies in primary biliary cholangitis

Increased Sensitivity of Gp210 Autoantibody Detection Using a Newly Designed Gp210 Antigen.

The Significance of Antimitochondria Antibody-M2 Subtype (AMA-M2) to Primary Biliary Cirrhosis(PBC)

Immunoglobulin M: A Neglected Serum Biomarker in Treatment‐Naive Primary Biliary Cholangitis with Normal Alkaline Phosphatase

The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature

Analysis of Autoantibodies against Promyelocytic Leukemia Nuclear Body Components and Biochemical Parameters in Sera of Patients with Primary Biliary Cholangitis

The immunological and clinical significance of IgM in primary biliary cirrhosis

Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis

Clinical significance of conventional serum autoantibodies for various liver diseases in a Chinese population.

Detection of autoantibodies in 60 patients with primary biliary cirrhosis.

Implication of Increased Serum IL-31 for Primary Biliary Cholangitis.